Latest Insider Transactions at Nutex Health, Inc. (NUTX)
This section provides a real-time view of insider transactions for Nutex Health, Inc. (NUTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nutex Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nutex Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,350
+37.22%
|
$28,350
$21.46 P/Share
|
|
Aug 20
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
575
+10.68%
|
$9,775
$17.4 P/Share
|
|
Aug 19
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,300
+23.5%
|
$22,100
$17.85 P/Share
|
|
Jul 12
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
22,709
+1.23%
|
-
|
|
Jun 12
2024
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+40.54%
|
$0
$0.54 P/Share
|
|
May 30
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
2,986
+0.02%
|
$0
$0.66 P/Share
|
|
May 29
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
3,768
+0.02%
|
$0
$0.68 P/Share
|
|
May 28
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
48,394
+0.27%
|
$0
$0.7 P/Share
|
|
May 13
2024
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
17,330
+0.1%
|
$0
$0.69 P/Share
|
|
Mar 12
2024
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,505
+26.26%
|
-
|
|
Mar 12
2024
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
16,502
+26.83%
|
-
|
|
Nov 20
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
275,200
+0.1%
|
$0
$0.23 P/Share
|
|
Nov 17
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
224,800
+0.08%
|
$0
$0.23 P/Share
|
|
Nov 15
2023
|
Joshua De Tillio Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
140,000
+50.0%
|
$0
$0.24 P/Share
|
|
Sep 22
2023
|
Warren Hosseinion President |
SELL
Bona fide gift
|
Direct |
141,000
-56.7%
|
-
|
|
Aug 31
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
152,326
+0.06%
|
$0
$0.28 P/Share
|
|
Aug 30
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
305,947
+0.11%
|
$0
$0.31 P/Share
|
|
Aug 29
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
342,744
+0.13%
|
$0
$0.3 P/Share
|
|
Aug 28
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
198,983
+0.07%
|
$0
$0.28 P/Share
|
|
Jun 15
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+18.26%
|
$0
$0.42 P/Share
|
|
Jun 14
2023
|
Mitchell Creem Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+37.95%
|
$0
$0.43 P/Share
|
|
Jun 14
2023
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Open market or private purchase
|
Direct |
12,000
+29.63%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Cheryl Yvonne Grenas Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Michael Lee Reed Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
May 26
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
18,028
+0.01%
|
$0
$0.49 P/Share
|
|
May 25
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
482,088
+0.18%
|
$0
$0.49 P/Share
|
|
May 19
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
385,000
+0.14%
|
$0
$0.58 P/Share
|
|
May 18
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
114,884
+0.04%
|
$0
$0.48 P/Share
|
|
May 18
2023
|
John J Waters Director |
BUY
Open market or private purchase
|
Direct |
50,000
+20.3%
|
$0
$0.47 P/Share
|
|
Apr 01
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,505
+36.17%
|
-
|
|
Apr 01
2023
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
16,502
+50.0%
|
-
|
|
Dec 13
2022
|
Premier Macy Management Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
43,880
-0.1%
|
$87,760
$2.06 P/Share
|
|
Dec 12
2022
|
Premier Macy Management Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
125,498
-0.3%
|
$250,996
$2.21 P/Share
|
|
Sep 15
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
70,000
+21.95%
|
$140,000
$2.36 P/Share
|
|
Sep 15
2022
|
Michael Bowen Retired CFO |
BUY
Open market or private sale
|
Direct |
9,517
+2.13%
|
$19,034
$2.4 P/Share
|
|
Sep 14
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
130,000
+28.95%
|
$260,000
$2.46 P/Share
|
|
Sep 14
2022
|
Michael Bowen Retired CFO |
BUY
Open market or private sale
|
Direct |
483
+0.11%
|
$966
$2.6 P/Share
|
|
Sep 09
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
150,000
+25.04%
|
$300,000
$2.84 P/Share
|
|
Sep 07
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
100,000
+14.31%
|
$200,000
$2.99 P/Share
|
|
Sep 06
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
100,000
+12.52%
|
$200,000
$2.79 P/Share
|
|
Sep 02
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
180,000
+18.39%
|
$360,000
$2.48 P/Share
|
|
Sep 01
2022
|
Warren Hosseinion President |
BUY
Open market or private sale
|
Direct |
70,000
+6.67%
|
$140,000
$2.56 P/Share
|
|
Jun 20
2022
|
John J Waters Director |
BUY
Conversion of derivative security
|
Direct |
64,516
+30.61%
|
$64,516
$1.55 P/Share
|
|
May 10
2022
|
Thomas T. Vo Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
21,429
+0.08%
|
-
|
|
May 09
2022
|
Cheryl Yvonne Grenas Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,280
+50.0%
|
$57,840
$3.89 P/Share
|
|
May 09
2022
|
Michael Lee Reed Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,208
+50.0%
|
$63,624
$3.89 P/Share
|
|
May 09
2022
|
John J Waters Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,851
+50.0%
|
$65,553
$3.89 P/Share
|
|
May 09
2022
|
Mitchell Creem Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,208
+50.0%
|
$63,624
$3.89 P/Share
|
|
May 05
2022
|
Warren Hosseinion President |
SELL
Bona fide gift
|
Direct |
102,888
-8.93%
|
-
|
|
Apr 02
2022
|
Lawrence Schimmel Chief Medical Information Off |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
9,799
+3.59%
|
$9,799
$1.55 P/Share
|